183 related articles for article (PubMed ID: 30873627)
1. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
[TBL] [Abstract][Full Text] [Related]
2. A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C.
Lu JJ; Chen M; Lv CL; Zhang R; Lu H; Cheng DH; Tang SY; Liu TT
Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):535-546. PubMed ID: 32304024
[TBL] [Abstract][Full Text] [Related]
3. Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers.
Jing L; Liu TT; Guo Q; Chen M; Lu JJ; Lv CL
J Clin Pharm Ther; 2020 Feb; 45(1):88-96. PubMed ID: 31463971
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study.
Frazee EN; Rule AD; Herrmann SM; Kashani KB; Leung N; Virk A; Voskoboev N; Lieske JC
Crit Care; 2014 May; 18(3):R110. PubMed ID: 24887089
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.
Zhang R; Chen M; Liu TT; Lu JJ; Lv CL
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):135-149. PubMed ID: 31541402
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
8. Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?
DeCarolis DD; Thorson JG; Marraffa RA; Clairmont MA; Kuskowski MA
Ther Drug Monit; 2014 Oct; 36(5):632-9. PubMed ID: 25222855
[TBL] [Abstract][Full Text] [Related]
9. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C and/or creatinine-based estimated glomerular filtration rate for prediction of vancomycin clearance in long-stay critically ill patients with persistent inflammation, immunosuppression and catabolism syndrome (PICS): a population pharmacokinetics analysis.
Huang J; Wang X; Hao C; Yang W; Zhang W; Liu J; Qu H
Intern Emerg Med; 2021 Oct; 16(7):1883-1893. PubMed ID: 33728578
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
[TBL] [Abstract][Full Text] [Related]
12. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function.
Tanaka A; Aiba T; Otsuka T; Suemaru K; Nishimiya T; Inoue T; Murase M; Kurosaki Y; Araki H
Antimicrob Agents Chemother; 2010 Feb; 54(2):778-82. PubMed ID: 19933799
[TBL] [Abstract][Full Text] [Related]
15. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
16. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
[TBL] [Abstract][Full Text] [Related]
17. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease.
Samura M; Takada K; Yamamoto R; Ito H; Nagumo F; Uchida M; Kurata T; Koshioka S; Enoki Y; Taguchi K; Higashita R; Kunika N; Tanikawa K; Matsumoto K
Pharm Res; 2021 Jun; 38(6):1041-1055. PubMed ID: 34013390
[TBL] [Abstract][Full Text] [Related]
19. Estimation of safe and effective dose of vancomycin in MRSA-infected patients using serum cystatin C concentrations.
Chen YC; Feng JF; Li B; Zhang L; Yang YW
Int J Clin Pharmacol Ther; 2013 Mar; 51(3):161-9. PubMed ID: 23195915
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
